Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg Evers

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Plos One|April 18, 2014
Proteinase-Activated Receptor 1 (PAR1) regulates leukemic stem cell functionsNicole Bäumer, Annika Krause, Gabriele Köhler, et al.
Therapeutic Advances in Medical Oncology|March 31, 2022
Real-world multicentre analysis of neoadjuvant immunotherapy and chemotherapy in localized or oligometastatic non-small cell lung cancer (KOMPASSneoOP)Martin Faehling, Hanno Witte, Martin Sebastian, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 9, 2026
Survival Outcomes After Front-Line Consolidation With High-Dose Melphalan and Autologous Stem Cell Transplantation in Younger and Elderly Multiple Myeloma Patients: A Retrospective Bi-Centric AnalysisArne Strotmann, Theo Leitner, Paolo Mazzeo, et al.
Cancers|March 25, 2022
High Expression of NT5DC2 Is a Negative Prognostic Marker in Pulmonary AdenocarcinomaArik Bernard Schulze, Anna Kuntze, Lars Henning Schmidt, et al.
Anticancer Research|February 28, 2023
Efficacy of Multimodality Approach in Patients With Recurrent Head and Neck Squamous Cell CarcinomaPascale Alicia Hoell, Khaled Elsayad, Hendrik Berssenbruegge, et al.
Thoracic Cancer|November 25, 2019
Prognostic impact of CD34 and SMA in cancer-associated fibroblasts in stage I-III NSCLCArik Bernard Schulze, Lars Henning Schmidt, Birthe Heitkötter, et al.
Journal of Thoracic Disease|November 19, 2019
Blood clot removal by cryoextraction in critically ill patients with pulmonary hemorrhageLars Henning Schmidt, Arik Bernard Schulze, Dennis Goerlich, et al.
Translational Lung Cancer Research|May 17, 2023
High expression of transcription factor POU2F1 confers improved survival on smokers with lung adenocarcinoma: a retrospective study of two cohortsArik Bernard Schulze, Daniela Vanessa Wenge, Georg Evers, et al.
ACR Open Rheumatology|October 3, 2023
Type 1 Interferon-Stimulated Gene Expression and Disease Activity in Pediatric Rheumatic Diseases: No Composite Scores Needed?Christina Weiden, Melanie Saers, Tobias Schwarz, et al.
Canadian Respiratory Journal|March 4, 2022
Sustained Impairment in Cardiopulmonary Exercise Capacity Testing in Patients after COVID-19: A Single Center ExperienceGeorg Evers, Arik Bernard Schulze, Irina Osiaevi, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Plos One|April 18, 2014
Proteinase-Activated Receptor 1 (PAR1) regulates leukemic stem cell functionsNicole Bäumer, Annika Krause, Gabriele Köhler, et al.
Therapeutic Advances in Medical Oncology|March 31, 2022
Real-world multicentre analysis of neoadjuvant immunotherapy and chemotherapy in localized or oligometastatic non-small cell lung cancer (KOMPASSneoOP)Martin Faehling, Hanno Witte, Martin Sebastian, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 9, 2026
Survival Outcomes After Front-Line Consolidation With High-Dose Melphalan and Autologous Stem Cell Transplantation in Younger and Elderly Multiple Myeloma Patients: A Retrospective Bi-Centric AnalysisArne Strotmann, Theo Leitner, Paolo Mazzeo, et al.
Cancers|March 25, 2022
High Expression of NT5DC2 Is a Negative Prognostic Marker in Pulmonary AdenocarcinomaArik Bernard Schulze, Anna Kuntze, Lars Henning Schmidt, et al.
Anticancer Research|February 28, 2023
Efficacy of Multimodality Approach in Patients With Recurrent Head and Neck Squamous Cell CarcinomaPascale Alicia Hoell, Khaled Elsayad, Hendrik Berssenbruegge, et al.
Thoracic Cancer|November 25, 2019
Prognostic impact of CD34 and SMA in cancer-associated fibroblasts in stage I-III NSCLCArik Bernard Schulze, Lars Henning Schmidt, Birthe Heitkötter, et al.
Journal of Thoracic Disease|November 19, 2019
Blood clot removal by cryoextraction in critically ill patients with pulmonary hemorrhageLars Henning Schmidt, Arik Bernard Schulze, Dennis Goerlich, et al.
Translational Lung Cancer Research|May 17, 2023
High expression of transcription factor POU2F1 confers improved survival on smokers with lung adenocarcinoma: a retrospective study of two cohortsArik Bernard Schulze, Daniela Vanessa Wenge, Georg Evers, et al.
ACR Open Rheumatology|October 3, 2023
Type 1 Interferon-Stimulated Gene Expression and Disease Activity in Pediatric Rheumatic Diseases: No Composite Scores Needed?Christina Weiden, Melanie Saers, Tobias Schwarz, et al.
Canadian Respiratory Journal|March 4, 2022
Sustained Impairment in Cardiopulmonary Exercise Capacity Testing in Patients after COVID-19: A Single Center ExperienceGeorg Evers, Arik Bernard Schulze, Irina Osiaevi, et al.
Pageof 6